multivessel

mejor estrategia infarto agudo de miocardio y múltiples vasos

Best Strategy for Acute MI and Multivessel Disease

The goal of this study was to assess all available revascularization strategies for patients undergoing ST elevation acute myocardial infarction and multivessel disease. &nbsp; Among the strategies to treat this group of patients, there were: culprit vessel intervention only, culprit vessel intervention and, in case of success, multivessel intervention, culprit vessel intervention with staged revascularization,<a href="https://solaci.org/en/2017/01/14/best-strategy-for-acute-mi-and-multivessel-disease/" title="Read more" >...</a>

enfermedad de múltiples vasos síndrome coronario agudo

ACS and Multivessel Disease: How to proceed

Gentileza del Dr. Javier Castro &nbsp; In the daily practice, a high percentage of ST elevation myocardial infarction patients (STEMI) present multivessel disease (40-65%). This group of patients presents worse clinical evolution and higher mortality than patients with one culprit lesion. &nbsp; When PCI is indicated to a patient with significant lesions in more than<a href="https://solaci.org/en/2016/10/03/acs-and-multivessel-disease-how-to-proceed/" title="Read more" >...</a>

Surgery vs. PCI in Diabetic Patients with Multivessel Disease

Original Title: Revascularization in diabetics with multivessel disease: a population-based evaluation of outcomes. Presenter: Ramanathan K. Real-world data support the role of CABG over PCI in diabetic patients with multivessel disease. However, PCI continues to be a common ­­­­­­option for this patient population, according to an analysis of 2 Canadian registries. Sourcing data from 2<a href="https://solaci.org/en/2015/11/20/cirugia-vs-angioplastia-en-diabeticos-con-multiples-vasos-2/" title="Read more" >...</a>

FAME at 5 years: FFR Should Guide All Multivessel PCIs

Though the benefit of FFR (fractional flow reserve) over angiography is statistically important only over the first 2 years, this pattern is maintained at long term according to FAME 5 year follow up, presented at the ECS and simultaneously published in The Lancet. Between the second and fifth year, the number of patients at risk<a href="https://solaci.org/en/2015/11/16/fame-at-5-years-ffr-should-guide-all-multivessel-pcis/" title="Read more" >...</a>

When to proceed with multivessel PCI

André Kokis2012-08-07 Head of Interventional Cardiology&nbsp;Centre Hospitalier de l&rsquo;Universit&eacute; de Montr&eacute;alMontr&eacute;al, Canada

DANAMI3: Primary Angioplasty to culprit vessel versus multivessel guided by FFR

The aim of this study was to compare the usefulness of primary angioplasty only to culprit vessel versus complete revascularization guided by fractional flow reserve (FFR) in patients admitted pursuing an acute myocardial infarction with ST-segment elevation and have multiple injuries vessels. After a successful primary angioplasty to culprit artery, patients were randomized 1:1 to<a href="https://solaci.org/en/2015/06/24/congress-item-8848/" title="Read more" >...</a>

FREEDOM trial: CABG versus angioplasty treatment for diabetic patients with multivessel disease

The trial included 1,900 patients followed for at least 2 years, (mean 3.8 years), randomized 1:1 to pharmacological angioplasty stents, (sirolimus or paclitaxel at surgeon discretion), or CABG. We excluded acute coronary syndromes and left coronary trunk injury. The primary endpoint was death, myocardial infarction or stroke and the secondary main was the sum of<a href="https://solaci.org/en/2015/06/24/congress-item-6888/" title="Read more" >...</a>

FREEDOM: Insulin dependent versus non-insulin dependent with multivessel disease

From the total of 1900 patients in the FREEDOM study, 1248 did not require insulin (631 received angioplasty and 617 received CABG) and 602 if required (325 received angioplasty and 277 received CABG). Insulin dependent patients were more obese, with higher glycosylated hemoglobin, increased incidence of heart failure and increased incidence of acute coronary syndromes.<a href="https://solaci.org/en/2015/06/24/congress-item-6356/" title="Read more" >...</a>

Top